top of page

AGTC Genomics Joins Malaysian Stakeholder Forum on Genetic Testing, Insurance and Patient Protection

Nov 13
2 min read

KUALA LUMPUR, 11 November 2026 — AGTC Genomics, a leading Malaysian genomics testing laboratory serving healthcare and research partners across Southeast Asia, was invited to contribute to the stakeholder forum Genetic Information, Discrimination and Responsible Genomic Medicine in Malaysia. Held at Universiti Malaya on 11 November, the forum brought together patient advocates, clinicians, genetic counsellors, researchers, legal experts and insurance representatives to discuss how Malaysia can expand access to genomic medicine while protecting patients from genetic discrimination.


AGTC Genomics shared its perspective on making clinically appropriate genetic testing more affordable and accessible. The company highlighted the role of local testing capacity, transparent pricing and partnerships with hospitals and clinics. It also emphasised the importance of matching the test to the clinical question. In some cases, a focused test can give patients and doctors the information they need at a lower cost.


“Making genetic testing more affordable is only part of the work. A patient may still hesitate if they worry that learning about an inherited risk could affect their ability to obtain insurance. We want patients to understand what a test can tell them, how their information will be protected and who can see their results before they decide to proceed,” said Professor Chee-Onn Leong, Founder and Chief Executive Officer of AGTC Genomics.


Patients decide whether their report is shared with their doctor


AGTC Genomics handles patient information in accordance with Malaysia’s Personal Data Protection Act 2010 (PDPA) and draws on privacy and security practices reflected in the U.S. Health Insurance Portability and Accountability Act (HIPAA). These safeguards apply from the first consultation through sample processing, reporting and follow-up.


For patients who test directly with AGTC Genomics, the process starts with pre-test counselling by an in-house genetic counsellor. The laboratory performs the test and returns the report directly to the patient. Post-test counselling helps the patient understand the findings and their implications. AGTC Genomics shares the report with a doctor only with the patient’s permission. Within AGTC Genomics, access is limited to authorised personnel who need the information to provide the service.


AGTC Genomics thanks Cancer Research Malaysia, Universiti Malaya and the Genetic Counselling Society Malaysia for convening the forum.




About AGTC Genomics


AGTC Genomics is a Kuala Lumpur-based genomics laboratory providing clinical genetic testing, precision oncology and research sequencing services. Its molecular testing laboratory is accredited by the College of American Pathologists (CAP) and holds ISO 15189 accreditation for molecular testing.

 
 
 

Comments


bottom of page